𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Endoreduplication in conjunction with tumor progression in an aneuploid laryngeal squamous cell carcinoma

✍ Scribed by Michael J. Schwerer; Jörg Hemmer; Klaus Kraft; Heinz Maier; Peter Möller; Thomas F. E. Barth

Publisher
Springer
Year
2003
Tongue
English
Weight
294 KB
Volume
443
Category
Article
ISSN
1432-2307

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low COX2 in tumor and upregulation in st
Low COX2 in tumor and upregulation in stroma mark laryngeal squamous cell carcinoma progression
✍ Konstantinos Kourelis; Gerasimos Vandoros; Theodoros Kourelis; Theodoros Papadas 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 271 KB

## Abstract ## Objectives/Hypothesis: Invasive squamous cell carcinomas (SCC) of the larynx, like most solid tumors, are surrounded by a reactive stroma, in which cancer associated fibroblasts (CAFs) are the predominant cell type. This mesenchymal reaction may affect cancer progression multiply. T

Vascular endothelial growth factor expre
Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma : Association with angiogenesis and tumor progression
✍ Kimitoshi Inoue; Yuichi Ozeki; Toshiyuki Suganuma; Yoshiaki Sugiura; Susumu Tana 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 245 KB 👁 2 views

## Background: Angiogenesis is essential for solid tumor growth and metastasis. vascular endothelial growth factor (vegf), a recently identified growth factor with significant angiogenic properties, may be a major tumor angiogenesis regulator in vivo. conversely, there have been few studies of the

Galectins as modulators of tumor progres
Galectins as modulators of tumor progression in head and neck squamous cell carcinomas
✍ Sven Saussez; Isabelle Camby; Gerard Toubeau; Robert Kiss 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 364 KB 👁 2 views

## Abstract Head and neck squamous cell carcinomas (HNSCCs) remain a significant cause of morbidity worldwide. Biological therapies able to induce and/or upregulate antitumor immune responses could represent a complementary approach to conventional treatments for patients with HNSCC because, despit